Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors

Summary

Immunotherapy has become the major breakthrough and the most promising treatment, with the host of development of tumor biology, molecular biology and immunology. We have developed anti-ROBO1 CAR-NK cells that can target tumor cells highly expressing ROBO1. The purpose of this study is to evaluate the safety and effectiveness of cell therapy using ROBO1 CAR-NK cells to treat solid tumors.

Timeline

Start

2019-05

Primary completion

2021-05

Completion

2022-05

Drugs

Indications